Cost analysis of an integrated disease surveillance and response system : case of Burkina Faso , Eritrea , and Mali
暂无分享,去创建一个
M. Meltzer | W. Alemu | Nancy E. Messonnier | Z. C. Somda | Usman Abdulmumini | G. Mebrahtu | M. Sacko | K. Touré | Salimata Ouédraogo Ki | T. Okorosobo | I. Sow | Helen N. Perry | Massambou Sacko
[1] S. Thacker,et al. Planning an integrated disease surveillance and response system: a matrix of skills and activities , 2007, BMC medicine.
[2] Alan D. Lopez,et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.
[3] D. Evans,et al. Cost effectiveness analysis of strategies to combat malaria in developing countries , 2005, BMJ : British Medical Journal.
[4] J. Fox-Rushby,et al. The effects and costs of expanding the coverage of immunisation services in developing countries: a systematic literature review. , 2005, Vaccine.
[5] Julia Fox-Rushby,et al. Cost of delivering child immunization services in urban Bangladesh: a study based on facility-level surveys. , 2004, Journal of health, population, and nutrition.
[6] A. Uzicanin,et al. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa. , 2004, Vaccine.
[7] Steven Russell,et al. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. , 2004, The American journal of tropical medicine and hygiene.
[8] P. Strebel,et al. Cost-effectiveness of three different vaccination strategies against measles in Zambian children. , 2004, Vaccine.
[9] J. Sachs,et al. The economic and social burden of malaria , 2002, Nature.
[10] B. Perkins,et al. Technical guidelines for integrated disease surveillance and response in the African region , 2001 .
[11] B. Gessner,et al. Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: a theoretical modeling analysis. , 2001, Vaccine.
[12] D. Evans,et al. Critical issues in the economic evaluation of interventions against communicable diseases. , 2001, Acta tropica.
[13] J. Fox-Rushby,et al. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. , 2000, Health economics.
[14] M. Meltzer,et al. Costs and benefits of a subtype-specific surveillance system for identifying Escherichia coli O157:H7 outbreaks. , 2000, Emerging infectious diseases.
[15] V. Balraj,et al. Disease surveillance at district level: a model for developing countries , 1998, The Lancet.
[16] J. Barendregt,et al. Global burden of disease , 1997, The Lancet.
[17] 함일한,et al. Surveillance , 1996 .
[18] Anne Mills,et al. The economic impact of malaria in Africa: a critical review of the evidence. , 2003, Health policy.
[19] K. Barnes,et al. An economic comparison of chloroquine and sulfadoxine-pyrimethamine as first-line treatment for malaria in South Africa: development of a model for estimating recurrent direct costs. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[20] N. Ndayimirije,et al. Structure and performance of infectious disease surveillance and response, United Republic of Tanzania, 1998. , 2002, Bulletin of the World Health Organization.
[21] P. Jha,et al. The cost-effectiveness of forty health interventions in Guinea. , 1998, Health policy and planning.